Navigation Links
Global Orphan Drug Market Future Outlook 2015-2020
Date:6/8/2015

DUBLIN, June 08, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/g8q842/global_orphan) has announced the addition of the "Global Orphan Drug Market Future Outlook 2020" report to their offering.

In recent years, several new rare diseases are being included in clinical trials for the development of orphan drug candidate. Oncology, Genetic diseases, Autoimmune, pulmonary disease, Central nervous system and others are main focus of orphan drug developers. All of these diseases have large patient base but their rare forms doesn't have suitable therapeutics which reflects the marketing potential of orphan drugs in these segments.

Out of these, oncology segment has got maximum attention followed by rare genetic disorders, neurological disorder and autoimmune disorders. In a bigger view, orphan drug segment is expected to grow several folds in coming years due to several favorable factors. Introduction of innovative technologies, favorable pricing, reimbursement, unmet medical necessities and strong clinical pipeline could be attributed as important factors responsible for their growth.

"Global Orphan Drug Market Future Outlook 2020" report highlights:

- Global Orphan Drug Market Overview
- Global Orphan Drug Market Segment Analysis
- FDA & EMA Regulation for Clinical Trials Orphan Designated Drugs
- Orphan Drug Designation Criteria & Reimbursement Policy by Region
- Comprehensive Insight on Global Orphan Drugs Clinical Pipeline & Patent Analysis by Company, Country, Indication & Phase
- Global Orphan Drugs Clinical Pipeline: 697 Drugs
- Majority Orphan Drugs in Phase-II Trials: 249 Drugs
- Marketed Orphan Drugs: 274 Drugs

Key Topics Covered:

1. Introduction to Orphan Drug

2. Favorable Market Dynamics for Orphan Drugs Commercialization

3. Global Orphan Drug Market Overview

4. Global Orphan Drug Market Segment Analysis

5. Global Orphan Drug Clinical Pipeline Overview

6. US Orphan Drug Market Overview

7. Europe Orphan Drug Market Overview

8. Asia Orphan Drug Market Overview

9. FDA Regulation for Clinical Trials Orphan Designated Drugs

10. EMA Regulations for Clinical Trials of Orphan Designated Drugs

11. Asian Regulations for Clinical Trials of Orphan Designated Drugs

12. Global Orphan Drugs Clinical Pipeline Insight & Patent Analysis by Company, Country, Indication & Phase

13. Marketed Orphan Drugs Clinical Insight & Patent Analysis by Company, Country & Indication

14. Discontinued & Suspended Orphan Drugs in Clinical Trials

15. Competitive Landscape

- AOP Orphan
- Agenus
- Alexion
- Biogen Idec
- Bristol Myers Squibb
- Celgene
- Eli Lilly
- Genethon
- Genzyme Corporation
- Glaxosmithkline
- Merck
- Novartis Pharmaceuticals
- Orphan Europe
- Pfizer
- Prosensa
- Rare Disease Therapeutics
- Roche
- Sanofi
- Shire
- Teva Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/g8q842/global_orphan

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Streptavidin (CAS 9013-20-1): Market Research Report 2015
2. AbbVie to Present at Goldman Sachs 36th Annual Global Healthcare Conference
3. Global Healthcare Financial Analytics Market 2015 - Growth, Trends & Forecast To 2020
4. Quest Diagnostics to Speak at the Goldman Sachs 36th Annual Global Healthcare Conference
5. Isis Pharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
6. Global Halogen Surgical Light Industry Report 2015
7. Global Electric Surgical Liposuction Pump Industry Report 2015
8. Global Surgical Incision Closures Industry
9. Global Blood Processing Supplies and Equipment Industry
10. Elastomers: Applications and Global Markets
11. Global Laboratory Centrifuges Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2018)... ... December 06, 2018 , ... Every day, and especially during the ... the best way to clean up (and throw away) bacteria-filled messes, and to prevent ... washed, which can spread germs around other kitchen surfaces and increase the odds of ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... WHO: The ... worldwide , WHAT: Livestreaming of four keynote addresses and five spotlight sessions ... Care (see below for session descriptions and speakers) , WHEN: Beginning Tuesday, December 11 ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Cyber Regulatory Waters , **An FDAnews Webinar**, Tuesday, Dec. 18, 2018, 1:30 ... get, the more vulnerable they become. , Cybersecurity is becoming an everyday risk. ...
Breaking Medicine Technology:
(Date:12/5/2018)... ... 05, 2018 , ... Adam Devlin , co-founder and ... serve on Philadelphia Mayor James F. Kenney’s Commission on People with Disabilities. The ... a cognitive or physical disability. Devlin serves as the chair of the Behavioral ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... patient and family engagement with the use of the Precision Virtual Reality® ... provides Children’s National’s world-renowned neurosurgeons and physicians with a never-before view of ...
(Date:12/5/2018)... La. (PRWEB) , ... December 05, 2018 , ... ... Faith Partnership Initiative leadership training on January 26 at North Monroe Baptist Church, ... of four 2019 trainings, part of the agency’s effort to educate and equip ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... of this condition are poorly understood. It manifests on the face, especially the ... condition, it can cause enormous social and psychological problems. , Although it is ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
Breaking Medicine News(10 mins):